RecruitingNot ApplicableNCT05868408

Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants

Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants: a Double-blind, Randomized, Controlled, Multi-arm Trial


Sponsor

Société des Produits Nestlé (SPN)

Enrollment

234 participants

Start Date

Aug 17, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study will assess the effect of partially hydrolyzed, whey-based infant formulas on growth and gastrointestinal tolerance in healthy term infants.


Eligibility

Min Age: 0 DaysMax Age: 28 Days

Inclusion Criteria7

  • Written informed consent has been obtained from at least one parent (or other legally acceptable representative \[LAR\]), if applicable)
  • Infant gestational age ≥37 completed weeks
  • Infant birth weight of ≥2.5 kg and ≤4.5 kg
  • Singleton birth
  • Infant postnatal age ≤28 days (date of birth = day 0)
  • Mother has previously decided to fully formula-feed, and infant is no longer breastfeeding or receiving breast milk
  • Infant's parent(s)/LAR is of legal age of majority, must understand the informed consent form and other relevant study documents, and is willing and able to fulfill the requirements of the study protocol

Exclusion Criteria7

  • Chronic infectious, metabolic, genetic illness or other disease, including any condition that impacts feeding or growth
  • Major congenital or chromosomal abnormality known to affect growth (e.g., congenital heart disease, cystic fibrosis)
  • Maternal medical conditions known to affect infant growth (e.g., untreated preeclampsia or gestational diabetes)
  • Infants with special dietary needs other than standard infant formula
  • Infants with known (or symptoms suggestive of) cow's milk protein intolerance/allergy, or lactose intolerance or severe food allergies that impact diet
  • Child has other medical or psychiatric condition that, in the judgement of the investigator, would make the child inappropriate for entry into the study
  • Currently participating or having participated in another interventional clinical trial prior to enrollment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERControl Formula

Infant formula made with intact protein - minimum 1.8g protein/100kcal

OTHERExperimental Formula 1

Infant formula made with hydrolyzed protein - minimum 1.9g protein/100kcal

OTHERExperimental Formula 2

Infant formula made with hydrolyzed protein - minimum 1.9g protein/100kcal


Locations(3)

National Guard Hospital

Jeddah, Saudi Arabia

King Faisal Specialist Hospital and Research Center

Riyadh, Saudi Arabia

National Guard Hospital

Riyadh, Saudi Arabia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05868408


Related Trials